Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention

被引：73

作者：

Stephenson, Kathryn E. ^{[1
,2
]}

Wagh, Kshitij ^{[3
,4
]}

Korber, Bette ^{[3
,4
]}

Barouch, Dan H. ^{[1
,2
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA

[2] Ragon Inst Massachusetts Gen Hosp MIT & Harvard, Boston, MA 02114 USA

[3] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA

[4] New Mexico Consortium, Los Alamos, NM 87545 USA

来源：

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 | 2020年 / 38卷

基金：

美国国家卫生研究院;

关键词：

vaccine; broadly neutralizing antibody; HIV-1; viral diversity; prevention; bNAb; HUMAN-IMMUNODEFICIENCY-VIRUS; DEMAND PREEXPOSURE PROPHYLAXIS; CELLULAR IMMUNE-RESPONSES; MUCOSAL SHIV CHALLENGE; T-LYMPHOCYTE RESPONSES; HIGHLY PATHOGENIC SIV; ENVELOPE TRIMER; DOUBLE-BLIND; ANTIRETROVIRAL PROPHYLAXIS; ANTI-HIV-1; ANTIBODIES;

D O I：

10.1146/annurev-immunol-080219-023629

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Development of improved approaches for HIV-1 prevention will likely be required for a durable end to the global AIDS pandemic. Recent advances in preclinical studies and early phase clinical trials offer renewed promise for immunologic strategies for blocking acquisition of HIV-1 infection. Clinical trials are currently underway to evaluate the efficacy of two vaccine candidates and a broadly neutralizing antibody (bNAb) to prevent HIV-1 infection in humans. However, the vast diversity of HIV-1 is a major challenge for both active and passive immunization. Here we review current immunologic strategies forHIV-1 prevention, with a focus on current and next-generation vaccines and bNAbs.

引用

页码：673 / 703

页数：31

共 50 条

[31] Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities
Liu, Yubin
Cao, Wei
Sun, Ming
Li, Taisheng
[J]. EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 194 - 206
[32] Broadly neutralizing antibodies against HIV-1 and concepts for application
Gruell, Henning
Schommers, Philipp
[J]. CURRENT OPINION IN VIROLOGY, 2022, 54
[33] Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
van Gils, Marit J.
Sanders, Rogier W.
[J]. VIROLOGY, 2013, 435 (01) : 46 - 56
[34] Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies
Brinkkemper, Mitch
Sliepen, Kwinten
[J]. VACCINES, 2019, 7 (03)
[35] Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies(vol 23, pg 142, 2023)
Haynes, Barton F.
Wiehe, Kevin
Borrow, Persephone
Saunders, Kevin O.
Korber, Bette
Wagh, Kshitij
McMichael, Andrew J.
Kelsoe, Garnett
Hahn, Beatrice H.
Alt, Frederick
Shaw, George M.
[J]. NATURE REVIEWS IMMUNOLOGY, 2023, 23 (04) : 265 - 265
[36] Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies
Cheeseman, Hannah M.
Olejniczak, Natalia J.
Rogers, Paul M.
Evans, Abbey B.
King, Deborah F. L.
Ziprin, Paul
Liao, Hua-Xin
Haynes, Barton F.
Shattock, Robin J.
[J]. JOURNAL OF VIROLOGY, 2017, 91 (01)
[37] Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination
A. N. Vzorov
L. V. Uryvaev
[J]. Molecular Biology, 2017, 51 : 819 - 829
[38] Structural and Biochemical Characterization of Cysteinylation in Broadly Neutralizing Antibodies to HIV-1
Omorodion, Oluwarotimi
Wilson, Ian A.
[J]. JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (24)
[39] Lessons from babies: inducing HIV-1 broadly neutralizing antibodies
Georgia D Tomaras
Barton F Haynes
[J]. Nature Medicine, 2014, 20 : 583 - 585
[40] Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies
Haynes, BF
Fleming, J
St Clair, EW
Katinger, H
Stiegler, G
Kunert, R
Robinson, J
Scearce, RM
Plonk, K
Staats, HF
Ortel, TL
Liao, HX
Alam, SM
[J]. SCIENCE, 2005, 308 (5730) : 1906 - 1908

← 1 2 3 4 5 →